InTheZone Labs Progresses Towards Amazon Listing, Expands Affiliate Program, and Shares Promising Phase One Testing Updates
Nitches Inc (OTC:NICH) announced key developments for its brand InTheZone Labs. The company is finalizing its Amazon listing process, expected to complete next week. They've joined ShareASale and Awin affiliate networks, offering 20% commissions. Phase One testing of their product Focused Extreme with veterans, former NFL athletes, and medical professionals shows positive results in brain fog reduction and decreased coffee dependence. Testing will conclude by December 7. The company is forming an advisory board and positioning itself in the nutraceuticals market, projected to exceed $650 billion by 2027.
Nitches Inc (OTC:NICH) ha annunciato sviluppi chiave per il suo marchio InTheZone Labs. L'azienda sta finalizzando il processo di listing su Amazon, previsto per completarsi la prossima settimana. Hanno aderito alle reti di affiliazione ShareASale e Awin, offrendo commissioni del 20%. I test di Fase Uno del loro prodotto Focused Extreme con veterani, ex atleti NFL e professionisti medici mostrano risultati positivi nella riduzione della nebbia mentale e nella diminuzione della dipendenza dal caffè. I test si concluderanno entro il 7 dicembre. L'azienda sta formando un consiglio consultivo e si sta posizionando nel mercato dei nutraceutici, che si prevede supererà i 650 miliardi di dollari entro il 2027.
Nitches Inc (OTC:NICH) anunció desarrollos clave para su marca InTheZone Labs. La compañía está finalizando su proceso de listado en Amazon, que se espera complete la próxima semana. Se han unido a las redes de afiliación ShareASale y Awin, ofreciendo comisiones del 20%. Las pruebas de la Fase Uno de su producto Focused Extreme con veteranos, ex atletas de la NFL y profesionales médicos muestran resultados positivos en la reducción de la niebla mental y la disminución de la dependencia del café. Las pruebas concluirán para el 7 de diciembre. La compañía está formando una junta asesora y posicionándose en el mercado de nutracéuticos, que se proyecta que superará los 650 mil millones de dólares para 2027.
Nitches Inc (OTC:NICH)는 자사 브랜드 InTheZone Labs에 대한 주요 개발 사항을 발표했습니다. 회사는 다음 주에 완료될 것으로 예상되는 아마존 목록 프로세스를 마무리하고 있습니다. 그들은 ShareASale 및 Awin 제휴 네트워크에 가입하여 20%의 수수료를 제공합니다. Focused Extreme 제품의 1단계 테스트는 재향 군인, 전 NFL 선수 및 의료 전문가들과 함께 진행되었으며, 긍정적인 결과를 보였고, 특히 뇌 안개 감소 및 커피 의존도 감소에 효과적이었습니다. 테스트는 12월 7일에 마무리될 예정입니다. 회사는 자문 위원회를 구성하고 있으며, 2027년까지 6,500억 달러를 초과할 것으로 예상되는 영양제 시장에 자리 잡고 있습니다.
Nitches Inc (OTC:NICH) a annoncé des développements clés pour sa marque InTheZone Labs. L'entreprise finalise son processus de référencement sur Amazon, qui devrait être achevé la semaine prochaine. Ils ont rejoint les réseaux d'affiliation ShareASale et Awin, offrant des commissions de 20 %. Les tests de la Phase Une de leur produit Focused Extreme avec des vétérans, d'anciens athlètes NFL et des professionnels de la santé montrent des résultats positifs dans la réduction de la brume cérébrale et la diminution de la dépendance au café. Les tests devraient prendre fin d'ici le 7 décembre. L'entreprise forme un conseil consultatif et se positionne sur le marché des nutraceutiques, dont le chiffre d'affaires devrait dépasser 650 milliards de dollars d'ici 2027.
Nitches Inc (OTC:NICH) hat wesentliche Entwicklungen für seine Marke InTheZone Labs bekannt gegeben. Das Unternehmen schließt derzeit den Prozess zur Listung bei Amazon ab, der voraussichtlich in der nächsten Woche abgeschlossen sein wird. Sie sind den Affiliate-Netzwerken ShareASale und Awin beigetreten und bieten 20 % Provisionen an. Die erste Testphase ihres Produkts Focused Extreme mit Veteranen, ehemaligen NFL-Spielern und medizinischen Fachkräften zeigt positive Ergebnisse bei der Reduzierung von Gehirnnebel und der Verringerung der Koffeinabhängigkeit. Die Tests werden bis zum 7. Dezember abgeschlossen sein. Das Unternehmen bildet einen Beratungsausschuss und positioniert sich im Markt für Nutraceuticals, dessen Umsatz bis 2027 voraussichtlich 650 Milliarden US-Dollar überschreiten wird.
- Amazon.com listing finalization expected next week, expanding product accessibility
- Higher-than-average 20% commission rate offered through affiliate networks
- Positive preliminary testing results for Focused Extreme product
- Strategic positioning in growing nutraceuticals market ($650B by 2027)
- None.
LAS VEGAS, NV / ACCESSWIRE / November 25, 2024 / Nitches, Inc. (OTC:NICH) is excited to announce significant strides for its flagship brand, InTheZone Labs. As the year winds down, the company continues to pave the way for its products to redefine the nutraceutical space in 2025.
Amazon Listing in Progress
InTheZone Labs is in the final stages of integrating its product line with Amazon.com. The company expects the listing process to be finalized by next week, aligning inventory and systems with the website to ensure seamless fulfillment. This milestone will make InTheZone Labs' innovative bioceuticals more accessible to a wider audience, delivering the edge customers need to "Get In The Zone for 2025."
Affiliate Program Expansion Through ShareASale and Awin
InTheZone Labs has officially joined the ShareASale and Awin affiliate networks, offering partners a lucrative opportunity to promote premium, American-made supplements. Affiliates receive
Phase One Testing Results to Be Completed by December 7
InTheZone Labs has been conducting rigorous Phase One testing with select groups, including U.S. veterans, former NFL athletes, a team led by a Doctor of Chiropractic, a traditional medical doctor, and other professionals. Preliminary feedback on InTheZone Focused Extreme has been overwhelmingly positive, showcasing notable benefits:
• Brain Fog Reduction: Participants reported significant clarity and focus throughout the day, even in high-stress or demanding environments.
• Decreased Coffee Dependence: Many testers noted they no longer needed their regular coffee intake, as Focused Extreme provided sustained energy and mental sharpness.
• Workout Synergy: Several testers observed enhanced pre-workout focus, with effects lasting well beyond their exercise routines.
One key finding from the testing revealed that larger individuals, such as former NFL players, achieved optimal results with an adjusted dosage. This feedback underscores the importance of tailoring guidance for different body types, ensuring maximum efficacy for all users.
Building a Strong Advisory Board
As part of the next phase of growth, InTheZone Labs is assembling a board of advisors composed of leaders from its Phase One testing groups. These experts, ranging from medical professionals to elite athletes, bring invaluable insights to the brand's development and messaging strategies.
Market Potential and Financial Perspective
The global nutraceuticals market is projected to exceed
Looking Ahead
We believe the feedback from Phase One testing will validate InTheZone Labs' formulations and provide actionable insights for optimization. With its products set to launch on Amazon and a rapidly expanding affiliate network, the company is poised for a robust start to 2025.
"Our goal has always been to create supplements that deliver real, noticeable results," said John Morgan, CEO of Nitches, Inc. "The feedback from our testing groups has been invaluable, and we're excited to see how this momentum carries us into the new year. For those ready to unlock their potential, InTheZone Labs is the answer."
Sign Up As An Affiliiate
Affiliates and distributors interested in joining the InTheZone Labs movement are encouraged to sign up via ShareASale, Awin, or directly through the company's website at InTheZoneLabs.com.
:: LINK TO SHAREASALE :: https://account.shareasale.com/shareasale.cfm?merchantID=161689
Stay tuned for additional updates, including Phase One testing results on December 1 and the launch of all three products-Focused Extreme, Youth, and Passion-on Amazon.com.
FDA Disclaimer: The Food and Drug Administration has not evaluated these statements. These products are not intended to diagnose, treat, cure, or prevent any disease.
For more information, visit InTheZoneLabs.com.
Forward-Looking Statements:
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
View the original press release on accesswire.com
FAQ
When will InTheZone Labs (NICH) complete its Phase One testing?
What commission rate does InTheZone Labs (NICH) offer to affiliates?
When will InTheZone Labs (NICH) products be available on Amazon?
What are the key benefits reported in InTheZone Labs (NICH) Phase One testing?
